Cargando…
Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan
BACKGROUND: Post-approval research or monitoring is important to determine real-world safety of new products; however, evidence is scant for vemurafenib in Japanese patients. In Japan, a unique system is officially obligated to investigate post-approval safety. Here we report the first adverse drug...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797186/ https://www.ncbi.nlm.nih.gov/pubmed/28674996 http://dx.doi.org/10.1007/s12094-017-1706-2 |